Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 14 studies | 30% ± 13% | |
lung | 10 studies | 26% ± 8% | |
eye | 5 studies | 26% ± 9% | |
brain | 5 studies | 30% ± 13% | |
intestine | 5 studies | 19% ± 4% | |
bone marrow | 4 studies | 22% ± 3% | |
adipose | 4 studies | 27% ± 7% | |
uterus | 3 studies | 28% ± 12% | |
lymph node | 3 studies | 24% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 5263.24 | 21 / 21 | 100% | 22.30 | 504 / 504 |
esophagus | 100% | 4619.37 | 1445 / 1445 | 100% | 22.85 | 183 / 183 |
intestine | 100% | 5530.60 | 966 / 966 | 100% | 21.61 | 527 / 527 |
lung | 100% | 4892.18 | 578 / 578 | 100% | 24.19 | 1155 / 1155 |
ovary | 100% | 5391.08 | 180 / 180 | 100% | 12.23 | 430 / 430 |
breast | 100% | 5171.30 | 459 / 459 | 100% | 27.93 | 1117 / 1118 |
prostate | 100% | 4263.58 | 245 / 245 | 100% | 20.28 | 501 / 502 |
uterus | 100% | 4878.81 | 170 / 170 | 100% | 23.77 | 458 / 459 |
brain | 100% | 3582.14 | 2634 / 2642 | 100% | 22.54 | 705 / 705 |
pancreas | 100% | 2709.41 | 327 / 328 | 100% | 23.48 | 178 / 178 |
thymus | 100% | 4287.25 | 653 / 653 | 100% | 26.55 | 603 / 605 |
stomach | 100% | 3832.13 | 359 / 359 | 100% | 20.21 | 285 / 286 |
kidney | 100% | 3584.20 | 89 / 89 | 100% | 21.49 | 897 / 901 |
liver | 100% | 2541.50 | 226 / 226 | 99% | 16.65 | 403 / 406 |
skin | 100% | 5509.09 | 1809 / 1809 | 99% | 22.36 | 467 / 472 |
adrenal gland | 100% | 4021.78 | 258 / 258 | 98% | 19.60 | 225 / 230 |
adipose | 100% | 5529.22 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5637.16 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 23.79 | 29 / 29 |
muscle | 100% | 4219.34 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 5713.96 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 23.31 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.44 | 1 / 1 |
heart | 98% | 2791.42 | 843 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 3343.06 | 890 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 16.85 | 75 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042532 | Biological process | negative regulation of tyrosine phosphorylation of STAT protein |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0033140 | Biological process | negative regulation of peptidyl-serine phosphorylation of STAT protein |
GO_0007283 | Biological process | spermatogenesis |
GO_0030154 | Biological process | cell differentiation |
GO_0060716 | Biological process | labyrinthine layer blood vessel development |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
Gene name | GGNBP2 |
Protein name | Gametogenetin-binding protein 2 (Laryngeal carcinoma-related protein 1) (Protein ZNF403) Gametogenetin-binding protein 2 (Protein ZNF403) Gametogenetin-binding protein 2 |
Synonyms | LZK1 ZNF403 LCRG1 |
Description | FUNCTION: May be involved in spermatogenesis. FUNCTION: May be involved in spermatogenesis. . FUNCTION: May be involved in spermatogenesis. . |
Accessions | ENST00000611219.1 A0A087X1D7 A0A087X0E5 ENST00000621686.2 [Q9H3C7-1] ENST00000633772.1 ENST00000616019.1 Q9H3C7 A0A087X1N0 ENST00000613102.5 [Q9H3C7-1] ENST00000632761.1 ENST00000615952.1 ENST00000633758.1 |